Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration
NCT03680326
·
clinicaltrials.gov ↗
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Vitreomacular Interface
Interventions
DEVICE:
OCT
Sponsor
Hospital Hietzing